The soluble interleukin-2 receptor in rheumatic disease.

Suppr

超能文献

作者信息

Rubin L A

机构信息

Division of Rheumatology, Sunnybrook Medical Centre, Toronto, Ontario, Canada.

出版信息

Arthritis Rheum. 1990 Aug;33(8):1145-8. doi: 10.1002/art.1780330814.

DOI:10.1002/art.1780330814

PMID:2390120

Abstract

摘要

相似文献

The soluble interleukin-2 receptor in rheumatic disease.

Arthritis Rheum. 1990 Aug;33(8):1145-8. doi: 10.1002/art.1780330814.

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.风湿性疾病患者血清和滑液中可溶性肿瘤坏死因子受体水平升高。

Arthritis Rheum. 1992 Oct;35(10):1160-9. doi: 10.1002/art.1780351008.

Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and interleukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis and Reiter's syndrome.人血清和滑液中的白细胞介素2及白细胞介素2抑制剂。II. 类风湿性关节炎、银屑病关节炎及赖特综合征中的促有丝分裂刺激、白细胞介素2生成及白细胞介素2受体表达

J Rheumatol. 1989 Jul;16(7):897-903.

Simultaneous evaluation of membrane bound and soluble interleukin 2 receptor expression in the blood and synovial fluid of patients with rheumatoid arthritis.

Clin Exp Rheumatol. 1990 Nov-Dec;8(6):579-82.

Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.类风湿关节炎、反应性关节炎和骨关节炎患者血清及滑液中肿瘤坏死因子和白细胞介素-2的可溶性受体

J Rheumatol. 1995 Mar;22(3):406-12.

A1 and A2 adenosine receptors in synovial cells from patients with rheumatic diseases.

Adv Exp Med Biol. 1989;253B:429-33. doi: 10.1007/978-1-4684-5676-9_63.

Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.可溶性白细胞介素-2受体：类风湿关节炎患者血清和滑液中的水平升高。

J Clin Lab Anal. 1990;4(2):130-4. doi: 10.1002/jcla.1860040211.

[Soluble IL-2 receptor levels in rheumatic diseases].[风湿性疾病中可溶性白细胞介素-2受体水平]

Ryumachi. 1993 Jun;33(3):229-34.

beta-Endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders.β-内啡肽、风湿性疾病滑液中的免疫和生化变化

Clin Rheumatol. 1986 Jan;5(1):25-32. doi: 10.1007/BF02030964.

Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.类风湿关节炎中的可溶性白细胞介素-2受体。与疾病活动度、白细胞介素-1和白细胞介素-2抑制的相关性。

J Immunol. 1988 Oct 15;141(8):2612-8.

引用本文的文献

Macrophage activation syndrome: advances towards understanding pathogenesis.巨噬细胞活化综合征：对发病机制认识的进展。

Curr Opin Rheumatol. 2010 Sep;22(5):561-6. doi: 10.1097/01.bor.0000381996.69261.71.

Continuity of cytokine activation in patients with familial Mediterranean fever.家族性地中海热患者细胞因子激活的持续性。

Clin Rheumatol. 2004 Aug;23(4):333-7. doi: 10.1007/s10067-004-0925-4. Epub 2004 May 1.

Advances in interleukin 2 receptor targeted treatment.白细胞介素2受体靶向治疗的进展

Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i109-14. doi: 10.1136/ard.59.suppl_1.i109.

Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis.类风湿关节炎患者在小剂量甲氨蝶呤治疗期间可溶性白细胞介素-2受体和白细胞介素-6的变化

Clin Rheumatol. 1996 Mar;15(2):218-9. doi: 10.1007/BF02230349.

Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmacytic malignancy in a man presenting as polymyalgia rheumatica.

Ann Rheum Dis. 1993 Feb;52(2):158-60. doi: 10.1136/ard.52.2.158.

Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.尿新蝶呤作为系统性红斑狼疮患者疾病活动的一个参数：与血清可溶性白细胞介素-2受体、抗双链DNA抗体、红细胞沉降率以及血浆C3、C4和C3降解产物的比较

Ann Rheum Dis. 1993 Jun;52(6):429-35. doi: 10.1136/ard.52.6.429.

Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease.系统性红斑狼疮、进行性系统性硬化症和混合性结缔组织病患者可溶性肿瘤坏死因子（TNF）受体及TNF受体抗体的评估

J Clin Immunol. 1993 Sep;13(5):321-8. doi: 10.1007/BF00920240.

Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies.血清阴性脊柱关节病中白细胞介素1-β、肿瘤坏死因子-α、可溶性白细胞介素2受体及可溶性CD8的血清水平。

Rheumatol Int. 1994;13(5):175-80. doi: 10.1007/BF00390264.

Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate.对接受口服甲氨蝶呤治疗的幼年类风湿关节炎患儿进行可溶性白细胞介素2受体水平（sIL2-R）的系列测量。

Ann Rheum Dis. 1994 Jul;53(7):471-4. doi: 10.1136/ard.53.7.471.

Urine neopterin: a new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus.尿新蝶呤：系统性红斑狼疮患者疾病活动度连续监测的新参数。

Ann Rheum Dis. 1994 Nov;53(11):743-8. doi: 10.1136/ard.53.11.743.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验